PMGC Holdings Inc. (ELAB)
ELAB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.96
-2.95% on the day
Market cap
$2.4M
Nano cap
Revenue · 2025
$590K
Prior year not contiguous
Net income · 2025
-$7.7M
-1313.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ELAB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2023 |
| SEC CIK | 0001840563 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $590K |
| Net income | -$7.7M |
| Operating income | Not in SEC XBRL data |
| Net margin | -1313.0% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | $12.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 4.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-04-20 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-30 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-18 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-05-15 |
Source: SEC EDGAR submissions feed, 269 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MTNB | Matinas Biopharma Holdings Inc. | $2.50 | -8.76% | $2.4M |
| SPRC | SciSparc Ltd. | $3.94 | -3.43% | $2.3M |
| PPBT | Purple Biotech Ltd. | $1.36 | -1.45% | $2.2M |
| GOVX | GeoVax Labs Inc. | $0.2656 | -5.92% | $2.7M |
| SILO | Silo Pharma Inc. | $1.22 | -18.12% | $2.1M |
| GNPX | Genprex Inc. | $2.51 | -6.69% | $2.1M |
| KAPA | Kairos Pharma Ltd. | $0.8287 | -0.40% | $2.8M |
| HCWB | HCW Biologics Inc. | $1.26 | -14.87% | $2.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier